about
T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioningTargeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures.Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families.The phenotypic spectrum of SCN8A encephalopathy.Rare copy number variants are an important cause of epileptic encephalopathies.GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome.Autobiographical memory in children with Idiopathic Generalised Epilepsy.Autobiographical memory in children with temporal lobe epilepsy.Outcome of Early Juvenile Onset Metachromatic Leukodystrophy After Unrelated Cord Blood Transplantation: A Case Series and Review of the Literature.Eye movement disorders are an early manifestation of CACNA1A mutations in children.Corpus callosotomy outcomes in pediatric patients: A systematic review.Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.Reduced complications from intracranial grid insertion by using a small grid size and a precise protocol during monitoring.Etiological associations and outcome predictors of acute electroencephalography in childhood encephalitis.Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: Clinical and etiologic risk factors.Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotypeThe respiratory control of carbon dioxide in children and adolescents referred for treatment of psychogenic non-epileptic seizuresReduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers.Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies.Longitudinal study of accelerated long-term forgetting in children with genetic generalized epilepsy: Evidence of ongoing deficits.Psychogenic non-epileptic seizures in children and adolescents: Part II - explanations to families, treatment, and group outcomes.Psychogenic non-epileptic seizures in children and adolescents: Part I - Diagnostic formulations.Febrile infection-related epilepsy syndrome is not caused by SCN1A mutations.Mortality in Dravet syndrome.Role of the sodium channel SCN9A in genetic epilepsy with febrile seizures plus and Dravet syndrome.Atypical multifocal Dravet syndrome lacks generalized seizures and may show later cognitive decline.Seizure outcome after corpus callosotomy in a large paediatric series.The spectrum of SCN1A-related infantile epileptic encephalopathies.EpApp: Development and evaluation of a smartphone/tablet app for adolescents with epilepsy.Accelerated long-term forgetting in children with temporal lobe epilepsy.Accelerated long-term forgetting in children with idiopathic generalized epilepsy.Accelerated long-term forgetting and behavioural difficulties in children with epilepsy.Attention deficits in children with epilepsy: Preliminary findings.De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study.VGKC antibodies in pediatric encephalitis presenting with status epilepticus.Dealing with a first seizure: accurate diagnosis and good managementRisk factors for complications during intracranial electrode recording in presurgical evaluation of drug resistant partial epilepsyDiagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy
P50
Q24297141-25DFA1C5-B28B-4E24-90E7-4209B084E58FQ24602558-C365308A-D044-4A4B-A1B8-D0ACF317DE09Q27349308-8987A971-9BA6-42C2-8D44-84960B0EFBEAQ34611842-32600CDB-FD5C-466B-AAC3-45D7BD481EA8Q35106483-DBEB8656-6002-4CF4-B8D8-F410345CB251Q35632675-321F9ACC-CCAD-47D9-936C-03F57F15E8EBQ37725930-CA891D3D-B786-4F5E-B46D-E3A08E18685DQ38387224-64DF7491-B046-40C4-86E6-288C406AF6DBQ38420077-F37052AC-47CE-466A-B77E-782E7C353840Q38444298-9D24C782-5D73-4FB0-907D-12A84C098DA1Q38549684-01E373BB-E851-4CAA-BA16-FFD3F685074DQ38712800-6C2785AE-619A-44C2-AA4E-B789A6D39985Q38847503-68E5FE53-69EF-48CD-A0DA-9E4AD454A605Q40229229-4D08F849-0C15-4D41-B923-9E0259D596D1Q40234337-DDD59952-0C81-4073-A683-A04484C0B75AQ40577147-D4CBB0D7-F84C-4B73-AE88-F639A38FA596Q40900507-6DCEFBFF-67CA-415E-86B1-4CA2DD354E71Q41543515-E443448F-757F-42DD-BC84-682DDFCE18E8Q42162571-60B708E1-0A71-4F32-9E5C-CB6353269C7CQ45171119-671819A7-BBA8-491C-A1D4-67DCBBEB0A13Q45730334-8CC87983-B085-4DDD-8279-923F9DB41B4AQ46101453-C1480388-4506-410B-8F2A-64077369C2BBQ47258080-372DABA3-C807-40C0-81CA-42FCC2F9A965Q47611379-196F7C72-0C5A-4D69-B92A-E34010D85B19Q47780292-C5C5217C-F7CB-4728-B067-0A06E2C38A37Q47888090-F5A70F0F-CFD3-43F4-A809-B71CF924A2A8Q47910558-0F0470C3-CC66-412E-93A9-39344B564E50Q48033009-927F2865-7862-49A2-AA35-4C1785E90A21Q48147732-86214275-83BE-42D3-92A1-A40E565495B3Q48249670-FB9E2752-14EF-4767-83D1-BF2E50635933Q50107978-435D401B-2FF1-49C6-86E4-ECD2F689C7A9Q50646135-C157739F-CC26-4051-8A48-1C0DD87D837EQ50739620-C07FBDB7-8C82-4C83-A244-A53A61568E58Q53403764-4E736440-312B-4840-9E28-76B180659624Q53576447-CA5703CC-FA78-4669-AA87-CC4255CADF0FQ54600675-0B84C63B-800E-4943-9953-F5C603F90F11Q55463270-1FF7D163-5FF4-4F0C-A86F-FD0DDA5BAC4DQ57182595-48704DFC-00B5-4A45-80AC-E9FF8CA147A3Q83158722-1DD3784E-210A-45C4-AC6E-325EF4267582Q88934750-5FE555AB-23B7-402F-91EF-F3B0F070DDA9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Deepak Gill
@ast
Deepak Gill
@en
Deepak Gill
@es
Deepak Gill
@nl
type
label
Deepak Gill
@ast
Deepak Gill
@en
Deepak Gill
@es
Deepak Gill
@nl
prefLabel
Deepak Gill
@ast
Deepak Gill
@en
Deepak Gill
@es
Deepak Gill
@nl
P106
P31
P496
0000-0002-6219-9479